NOC vs VTAK · P/E 17, rev $20.76B vs rev $1.5M
Northrop Grumman Corporation (NOC) versus Catheter Precision Inc. (VTAK) — a side-by-side from cached financials, not a winner call.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Catheter Precision Inc. (VTAK) is a medical devices company listed on US.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Latest reported VTAK revenue for 2026-06-30 was $1.5M. Net income was -$5.0M. VTAK currently screens at market cap $3.0M.
NOC currently screens at market cap $78.14B and trailing P/E 17.2. VTAK currently screens at market cap $3.0M.
Not investment advice. Open the NOC and VTAK stock pages for the full models.
Not investment advice.